EP 1490345 A2 20041229 - NOVEL COMPOUND
Title (en)
NOVEL COMPOUND
Title (de)
NEUE VERBINDUNG
Title (fr)
NOUVEAU COMPOSE
Publication
Application
Priority
- EP 0303338 W 20030327
- GB 0207447 A 20020328
Abstract (en)
[origin: WO03082834A2] Compound of formula (I); which is;3-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]--amino}methyl)-N-ethylbenzamide;and salts and solvates thereof, a process for its preparation, pharmaceutical formulations containing it and its use in therapy.
IPC 1-7
C07D 265/30; C07C 229/60; C07C 215/18; A61K 31/5375; A61P 29/00
IPC 8 full level
A61P 29/00 (2006.01); C07D 265/30 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 11/06 (2017.12); A61P 17/06 (2017.12); A61P 25/28 (2017.12); A61P 27/16 (2017.12); A61P 29/00 (2017.12); A61P 31/18 (2017.12); A61P 37/08 (2017.12); C07D 265/30 (2013.01)
Citation (search report)
See references of WO 03082834A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03082834 A2 20031009; WO 03082834 A3 20040325; AR 039176 A1 20050209; AU 2003226758 A1 20031013; AU 2003226758 A8 20031013; EP 1490345 A2 20041229; GB 0207447 D0 20020508; JP 2006504626 A 20060209; TW 200401771 A 20040201
DOCDB simple family (application)
EP 0303338 W 20030327; AR P030101089 A 20030327; AU 2003226758 A 20030327; EP 03745295 A 20030327; GB 0207447 A 20020328; JP 2003580302 A 20030327; TW 92106774 A 20030326